NasdaqGS:RXRXBiotechs
Does AI Data Deal And New CMO Hire Change The Bull Case For Recursion (RXRX)?
In March 2026, Recursion Pharmaceuticals reported an expanded partnership with Citeline to integrate real-world data into its AI-enabled drug development platform, and announced that oncology veteran Vicki Goodman, M.D., will become Chief Medical Officer as of April 6, 2026, succeeding David Mauro, M.D., Ph.D.
Together, the data partnership and leadership change highlight Recursion’s push to strengthen clinical execution, particularly in oncology, by combining advanced analytics with deep...